427 Plasma and urinary pharmacokinetics of the novel, oral SHIP1 activator, AQX-1125 in interstitial cystitis/bladder pain syndrome (IC/BPS): Results of the phase2 LEADERSHIP trial
European Urology Supplements（2016）
关键词
cystitis/bladder pain syndrome,urinary pharmacokinetics,oral ship1 activator,interstitial cystitis/bladder
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要